Reasons for bullish bias: - Bounce from strong support - Bullish engulfing candle formed at weekly closing Entry Level(CMP): 75.58 Stop Loss Level: 71.20 Take Profit Level 1: 79.96 Take Profit Level 2: 84.34 Take Profit Level 3: Open
If you haven`t bought GILD before the previous earnings: Then analyzing the options chain and the chart patterns of GILD Gilead Sciences prior to the earnings report this week, I would consider purchasing the 80usd strike price Calls with an expiration date of 2024-6-21, for a premium of approximately $3.10. If these options prove to be profitable prior to the...
If you haven`t bought GILD on the Remdesivir approval: Then analyzing the options chain and the chart patterns of GILD Gilead Sciences prior to the earnings report this week, I would consider purchasing the 80usd strike price in the money Calls with an expiration date of 2024-1-19, for a premium of approximately $4.25. If these options prove to be profitable...
Reuters Adage Capital Partners GP LLC Dissolves Share Stake In Moderna, Takes In Gilead Sciences! Reuters: Germany requests 5% of EU supply of remdesivir Germany has requested around 5% of the supply of remdesivir under a six-month European Union supply deal, its health ministry said on Monday, despite criticism of the deal due to a lack of evidence about the...
GILEAD SCIENCES, D1: Support zone + 4X Divergence + Nice discount + Breakout of resistance line
Based on Technical Analysis the best option is to hold and wait the end of the price retracement before going long. Trump has been treated with Gilead Sciences remdesivir.